Regulation 3 Amendment of Schedule 2 to the PLPS Regulations and transitional provisions
Schedule 2 to the PLPS Regulations (applications in respect of pharmaceutical lists and the procedures to be followed) is amended in accordance with paragraphs (2) and (3).
In Part 1 (information to be included in routine and excepted applications), in paragraph 3 (fitness information about individuals: routine and excepted applications for inclusion in a pharmaceutical list)f1, omit sub-paragraph (8).
In Part 4 (determination and deferral of applications), in paragraph 23 (additional matters for consideration in relation to applications for inclusion in a pharmaceutical list)f2, in sub-paragraph (1), omit paragraph (c).
Where, before the day on which this regulation comes into force, it was necessary to include information in an application for inclusion in a pharmaceutical list by virtue of paragraph 3(8) of Schedule 2 to the PLPS Regulations—
if that information was not provided before that day, or the obligation to provide that information was only partially discharged before that day, it is no longer necessary for the applicant to provide that information, or the rest of that information, pursuant to that paragraph 3(8); but
if the applicant or a referee has provided or does provide information in the form of a reference or details of a referee either prior to or notwithstanding the revocation of paragraphs 3(8) and 23(1)(c) of Schedule 2 to the PLPS Regulations, NHS England may—
have regard to that information for the purposes of its consideration of the application, and
request further information or documentation from the applicant pursuant to paragraph 11 of Schedule 2 to the PLPS Regulationsf3 (relevant information or documentation), which it considers to be missing relevant information or documentation as a consequence of its consideration of that information.
Annotations
Footnotes
- f1
-
Paragraph 3 has been amended by S.I. 2023/479 and 1071.
- f2
-
The relevant amending instrument is S.I. 2023/1071.
- f3
-
Amended by S.I. 2023/1071.